GeneDx Holdings Corp. updated earnings guidance for the year 2024. For the year, the company now expects revenues to be between $235 million and $245 million (previous guidance was $220 million to $230 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.61 USD | -3.83% | -4.81% | +613.09% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+613.09% | 513M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+2.72% | 2.63B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Updates Earnings Guidance for the Year 2024